Article Details

Camizestrant extends PFS in advanced ER-positive breast cancer - Healio

Retrieved on: 2022-10-29 16:13:33

Tags for this article:

Click the tags to see associated articles and topics

Camizestrant extends PFS in advanced ER-positive breast cancer - Healio. View article details on hiswai:

Excerpt

... according to the agent's manufacturer.Camizestrant (AstraZeneca) is a next-generation oral selective estrogen receptor degrader (SERD).

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up